B. AKINCI, "Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes," NEW ENGLAND JOURNAL OF MEDICINE , vol.380, no.19, pp.1881, 2019
AKINCI, B. 2019. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. NEW ENGLAND JOURNAL OF MEDICINE , vol.380, no.19 , 1881.
AKINCI, B., (2019). Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. NEW ENGLAND JOURNAL OF MEDICINE , vol.380, no.19, 1881.
AKINCI, BARIŞ. "Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes," NEW ENGLAND JOURNAL OF MEDICINE , vol.380, no.19, 1881, 2019
AKINCI, BARIŞ. "Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes." NEW ENGLAND JOURNAL OF MEDICINE , vol.380, no.19, pp.1881, 2019
AKINCI, B. (2019) . "Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes." NEW ENGLAND JOURNAL OF MEDICINE , vol.380, no.19, p.1881.
@article{article, author={BARIŞ AKINCI}, title={Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2019, pages={1881} }